-
Sep 3, 2025, 08:00 AM
by
• New PhysioMimix in silico tools unlock deeper functional insights from existing assays, advancing translation of MPS data to predict human ADME behavior
• End-to-end support from experimental design to data interpretation
Full story
-
Sep 3, 2025, 08:00 AM
by
PhenoTips, based in Toronto, has developed a first-of-its-kind cloud-based software that streamlines and digitizes genomic health record management, saving clinicians time and supporting precision medicine initiatives. In June 2025, PhenoTips was one of 13 Ontario-based life sciences companies to receive the renewed Life Sciences Innovation Fund from the government of Ontario, through the Ontario Centre of Innovation (OCI).
Full story
-
Sep 3, 2025, 08:00 AM
by
Ametris (formerly ActiGraph), a global digital health solutions provider transforming real-world patient data into validated clinical evidence, announced the launch of Digital Endpoint Collaboration to accelerate Outcome DEvelopment (DECODE) in Obesity.
Full story
-
Sep 3, 2025, 01:00 AM
by
User Not Found
Bio-IT World| A large segment of the population holds negative views towards psychedelics, even in therapeutic contexts. Up until a few years ago, those people included Kosuke Kato, Ph.D., assistant professor of medicine at Baylor College of Medicine. His perspective changed when he and Louise Hecker, Ph.D., then working at Emory University, began reading up on the experimental use of psilocybin in treating various psychiatric and age-related neurodegenerative diseases.
Full story
-
Sep 2, 2025, 01:00 AM
by
User Not Found
Bio-IT World | Researchers at the Icahn School of Medicine at Mount Sinai have published a machine learning model to predict penetrance of genetic variants—how likely the variants are to cause disease. The tool combines genomic and clinical phenotype data to evaluate penetrance at scale, offering refined, individualized disease risk estimates. The study was published last week in Science (DOI: 10.1126/science.adm7066).
Full story
-
Aug 28, 2025, 10:01 AM
by
Full story
-
Aug 28, 2025, 10:01 AM
by
• Qureight’s advanced AI 3D imaging platform to be used across clinical trial to evaluate anatomical lung changes in adult patients, including during patient enrolment
• CAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplifier of the multiple pro-fibrotic pathways active in IPF
Full story
-
Aug 28, 2025, 10:01 AM
by
Rousselot announces promising preclinical results from a study conducted by Cellbricks Therapeutics, a Berlin-based biotech startup and spin-off from the Technical University of Berlin. As a pioneer in 3D-bioprinting, Cellbricks successfully implanted 3D-bioprinted adipose tissue constructs into mice, with no signs of fibrosis or rejection observed after seven weeks.
Full story
-
Aug 28, 2025, 10:01 AM
by
Full story
-
Aug 28, 2025, 10:01 AM
by
Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx
Full story
-
Aug 28, 2025, 01:00 AM
by
User Not Found
Bio-IT World| Ultima Genomics unveiled updates on the single-nucleotide variant (SNV) detection capabilities of its plus-minus sequencing (ppmSeq) technology, which were published at bioRxiv. The updates elaborate beyond the limits of currently available minimal residual disease assays.
Full story
-
Aug 27, 2025, 08:24 AM
by
Huateng Pharma offers reliable cosmetic ingredients including Diethylamino Hydroxybenzoyl Hexyl Benzoate, Tetrahydrocurcumin, and Piroctone Olamine.
Full story
-
Aug 27, 2025, 01:00 AM
by
User Not Found
Bio-IT World| SetPoint Medical will advance commercialization of the SetPoint System, a first-of-its-kind neuroimmune modulation therapy for adults living with moderate-to-severe rheumatoid arthritis; Sava Technologies plan to accelerate regulatory approval and commercialization of its next-generation wearable; and more.
Full story
-
Aug 26, 2025, 01:00 AM
by
User Not Found
Bio-IT World| BioMed X announced the launch of a new collaboration with Novo Nordisk; 10x Genomics launched Xenium Protein, a new addition to its Xenium Spatial platform; and more.
Full story
-
Aug 22, 2025, 09:17 AM
by
Company becomes the first to centralize digital data review activities within a single platform as the industry focuses on clinical trial efficiency
Full story
-
Aug 21, 2025, 09:06 AM
by
Full story
-
Aug 21, 2025, 09:06 AM
by
Full story
-
Aug 21, 2025, 01:00 AM
by
User Not Found
Bio-IT World | During this week’s Bioprocessing Summit in Boston, M++ UltraPilot from LISURE was named the winner of the Best of Show People’s Choice Award competition. Other finalists and their products were also named and featured.
Full story
-
Aug 20, 2025, 09:21 AM
by
MMS, a global has announced that it has been chosen by Friends of Cancer Research to support the development of practical decision frameworks to inform the interpretation of interim overall survival data in oncology clinical trials.
Full story
-
Aug 20, 2025, 01:00 AM
by
User Not Found
Bio-IT World | A multi-generational family tree is helping researchers dramatically improve the accuracy of genomic variant calling, according to a new study published in Nature Methods. The research, led by scientists at Pacific Biosciences, introduces a comprehensive benchmarking dataset that could reshape how genomic technologies are trained and validated.
Full story